Terms: = Endocrine gland cancer AND CCND2, KIAK0002, 894, ENSG00000118971, P30279, MGC102758
157 results:
1. Survival time prediction in patients with high-grade serous ovarian cancer based on
He D; Zhang X; Chang Z; Liu Z; Li B
BMC Cancer; 2024 Mar; 24(1):337. PubMed ID: 38475819
[TBL] [Abstract] [Full Text] [Related]
2. Development of an Automatic Rule-Based Algorithm for the Detection of Ovarian cancer Recurrence From Electronic Health Records.
Lee S; Kim JH; Ha HI; Lim MC; Cho H
JCO Clin Cancer Inform; 2024 Mar; 8():e2300150. PubMed ID: 38442323
[TBL] [Abstract] [Full Text] [Related]
3. Ultrasound microflow patterns help in distinguishing malignant from benign thyroid nodules.
Li W; Gao L; Du Y; Wang Y; Yang X; Wang H; Li J
Cancer Imaging; 2024 Jan; 24(1):18. PubMed ID: 38268031
[TBL] [Abstract] [Full Text] [Related]
4. Comparison of the ADNEX and ROMA risk prediction models for the diagnosis of ovarian cancer: a multicentre external validation in patients who underwent surgery.
Landolfo C; Ceusters J; Valentin L; Froyman W; Van Gorp T; Heremans R; Baert T; Wouters R; Vankerckhoven A; Van Rompuy AS; Billen J; Moro F; Mascilini F; Neumann A; Van Holsbeke C; Chiappa V; Bourne T; Fischerova D; Testa A; Coosemans A; Timmerman D; Van Calster B
Br J Cancer; 2024 Apr; 130(6):934-940. PubMed ID: 38243011
[TBL] [Abstract] [Full Text] [Related]
5. Efficacy and safety of VEGF/VEGFR inhibitors for platinum-resistant ovarian cancer: a systematic review and meta-analysis of randomized controlled trials.
Huang D; Ke L; Cui H; Li S; Sun F
BMC Womens Health; 2024 Jan; 24(1):34. PubMed ID: 38218775
[TBL] [Abstract] [Full Text] [Related]
6. Strikingly low prevalence of pituitary incidentalomas in a teaching hospital in Uruguay.
Pineyro MM; Sosa N; Rivero F; Tripodi D; Negrotto M; Lima R
Front Endocrinol (Lausanne); 2023; 14():1254180. PubMed ID: 37829684
[TBL] [Abstract] [Full Text] [Related]
7. DNA Methylation Pattern in Somatotroph Pituitary Neuroendocrine Tumors.
Kober P; Rymuza J; Baluszek S; Maksymowicz M; Nyc A; Mossakowska BJ; Zieliński G; Kunicki J; Bujko M
Neuroendocrinology; 2024; 114(1):51-63. PubMed ID: 37699356
[TBL] [Abstract] [Full Text] [Related]
8. Semi-automatic fine delineation scheme for pancreatic cancer.
Zhan W; Yang Q; Chen S; Liu S; Liu Y; Li H; Li S; Gong Q; Liu L; Chen H
Med Phys; 2024 Mar; 51(3):1860-1871. PubMed ID: 37665772
[TBL] [Abstract] [Full Text] [Related]
9. Development and validation of nomograms for predicting the risk of central lymph node metastasis of solitary papillary thyroid carcinoma of the isthmus.
Li Y; Gao X; Guo T; Liu J
J Cancer Res Clin Oncol; 2023 Nov; 149(16):14853-14868. PubMed ID: 37598343
[TBL] [Abstract] [Full Text] [Related]
10. Prediction of metastatic pheochromocytoma and paraganglioma: a machine learning modelling study using data from a cross-sectional cohort.
Pamporaki C; Berends AMA; Filippatos A; Prodanov T; Meuter L; Prejbisz A; Beuschlein F; Fassnacht M; Timmers HJLM; Nölting S; Abhyankar K; Constantinescu G; Kunath C; de Haas RJ; Wang K; Remde H; Bornstein SR; Januszewicz A; Robledo M; Lenders JWM; Kerstens MN; Pacak K; Eisenhofer G
Lancet Digit Health; 2023 Sep; 5(9):e551-e559. PubMed ID: 37474439
[TBL] [Abstract] [Full Text] [Related]
11. Factors Influencing the Diagnostic Performance of Repeat Endoscopic Ultrasound-Guided Fine-Needle Aspiration/Biopsy after the First Inconclusive Diagnosis of Pancreatic Solid Lesions.
Cho JH; Kim J; Lee HS; Ryu SJ; Jang SI; Kim EJ; Kang H; Lee SS; Song TJ; Bang S
Gut Liver; 2024 Jan; 18(1):184-191. PubMed ID: 37317559
[TBL] [Abstract] [Full Text] [Related]
12. MiR-188-5p inhibits cell proliferation and migration in ovarian cancer via competing for ccnd2 with ELAVL1.
Zhang H; Yuan N; Che H; Cheng X
Cell Mol Biol (Noisy-le-grand); 2023 Mar; 69(3):69-74. PubMed ID: 37300687
[TBL] [Abstract] [Full Text] [Related]
13. Evaluation of the anticancer effect of telomerase inhibitor BIBR1532 in anaplastic thyroid cancer in terms of apoptosis, migration and cell cycle.
Turkmen E; Sogutlu F; Erdogan M; Biray Avci C
Med Oncol; 2023 Jun; 40(7):196. PubMed ID: 37284891
[TBL] [Abstract] [Full Text] [Related]
14. Profiling the metabolome of uterine fluid for early detection of ovarian cancer.
Wang P; Ma J; Li W; Wang Q; Xiao Y; Jiang Y; Gu X; Wu Y; Dong S; Guo H; Li M
Cell Rep Med; 2023 Jun; 4(6):101061. PubMed ID: 37267943
[TBL] [Abstract] [Full Text] [Related]
15. Ultrasonography-based radiomics and computer-aided diagnosis in thyroid nodule management: performance comparison and clinical strategy optimization.
Xia M; Song F; Zhao Y; Xie Y; Wen Y; Zhou P
Front Endocrinol (Lausanne); 2023; 14():1140816. PubMed ID: 37251675
[TBL] [Abstract] [Full Text] [Related]
16. Diagnostic value of CT enhancement degree in lymph node metastasis of papillary thyroid cancer: A comparison of enhancement, ratio, and difference.
Zhu J; Tian M; Zhang T; Zhu H; Wei P; Han Z
Front Endocrinol (Lausanne); 2023; 14():1103434. PubMed ID: 37033256
[TBL] [Abstract] [Full Text] [Related]
17. Trends in the incidence of head and neck cancer: A nationwide population-based study.
Yang TH; Xirasagar S; Cheng YF; Chen CS; Chang WP; Lin HC
Oral Oncol; 2023 May; 140():106391. PubMed ID: 37030023
[TBL] [Abstract] [Full Text] [Related]
18. Prognostic role and predictors of lymph node involvement in pancreatic neuroendocrine tumors.
Ren SJ; Tan QQ; Cao D; Ke NW; Liu XB; Wang X
Eur J Radiol; 2023 May; 162():110772. PubMed ID: 36940547
[TBL] [Abstract] [Full Text] [Related]
19. Diagnostic value of combining preoperative inflammatory markers ratios with CA199 for patients with early-stage pancreatic cancer.
Gu Y; Hua Q; Li Z; Zhang X; Lou C; Zhang Y; Wang W; Cai P; Zhao J
BMC Cancer; 2023 Mar; 23(1):227. PubMed ID: 36899319
[TBL] [Abstract] [Full Text] [Related]
20. Establishment and validation of a nomogram model for predicting distant metastasis in medullary thyroid carcinoma: An analysis of the SEER database based on the AJCC 8th TNM staging system.
Chen Z; Mao Y; You T; Chen G
Front Endocrinol (Lausanne); 2023; 14():1119656. PubMed ID: 36875492
[TBL] [Abstract] [Full Text] [Related]
[Next]
